Agency classClass IOur severity:Severe FDA (Devices)·Z-2645-2019·Announced 2019-10-09

Medtronic Recalls Sherpa NX Active Guiding Catheters Due to Material Loss

Medtronic Vascular is recalling 248 units of Sherpa NX Active Guiding Catheters because primary segment material may be lost, exposing underlying stainless-steel braid wires.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters."

Plain-English summary

Medtronic Vascular is recalling 248 units of the Sherpa NX Active Guiding Catheter, 6F RCB, .070", REF SA6RCB, for cardiovascular use. The recall is due to a potential for extensive loss of primary segment material, which may expose underlying stainless-steel braid wires on a subset of the 6F Sherpa catheters.

The affected units were distributed worldwide to the US, Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hong Kong, Ireland, Italy, Kazakhstan, Luxembourg, Moldova, Netherlands, Poland, Portugal, Russian Federation, Saudi Arabia, Slovakia, South Africa, Spain, Sweden, Taiwan, and the United Kingdom. The recall applies to all lot and serial numbers for the GTIN 00613994822918.

Healthcare providers and consumers should stop using the affected catheters and contact Medtronic Vascular for further instructions or replacement.

The recalled product

Product: SHERPA NX ACTIVE GUIDING CATHETER, 6F RCB, .070", REF SA6RCB. for cardiovascular use
Manufacturer: Medtronic Vascular
Category: Medical Device — Cardiovascular Catheter
Hazard: structural-defect
exposed-wires
Affected units: 248

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

GTIN: 00613994822918 All Lot/Serial Numbers

Distribution

Distribution scope not specified by the agency.

Part of a larger recall action

This product is one of 191 recalled by Medtronic Vascular under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 191 products in this recall →

Same manufacturer · Medtronic Vascular

See all →

Severe
Medtronic Angiographic Guidewire Components Shipped Without Required Sterilization
FDA (Devices) · 2021-06-23
Severe
Medtronic Guide Catheter Recalled Due to Potential Sterility Compromise
FDA (Devices) · 2021-03-17
Severe
Medtronic Guide Catheter Recalled Due to Potential Sterility Compromise
FDA (Devices) · 2021-03-17
High
Medtronic 6F Launcher Guide Catheter Recalled for Potential Sterility Compromise
FDA (Devices) · 2021-03-17
Severe
Medtronic Guide Catheter Recalled for Potential Sterility Compromise
FDA (Devices) · 2021-03-17

Same hazard · structural defect